Physician profile
Maroun T Dick
NPI 1942273826
$7,937.69
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,662 · 2020: $1,443 · 2021: $2,869 · 2022: $1,945 · 2024: $19.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $1,115.07 | 2020-2022 | |
| Eisai INC. | $1,049.81 | 2019-2022 | |
| Abbvie INC. | $709.88 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $538.17 | 2019-2022 | |
| Amgen INC. | $510.25 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $452.71 | 2019-2022 | |
| Ucb, INC. | $438.13 | 2019-2022 | |
| Lilly USA, LLC | $388.88 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $348.00 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $346.34 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $333.75 | 2022 | |
| Novartis Pharmaceuticals Corporation | $329.88 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $249.60 | 2021-2022 | |
| Allergan, INC. | $201.15 | 2020 | |
| Amneal Pharmaceuticals LLC | $177.18 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $160.90 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $150.92 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $133.76 | 2021-2022 | |
| Harmony Biosciences LLC | $89.19 | 2020-2021 | |
| Boston Scientific Corporation | $37.27 | 2022-2024 | |
| Lundbeck LLC | $35.73 | 2020-2022 | |
| Biogen, INC. | $35.39 | 2020-2021 | |
| Neurelis, INC. | $29.81 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $23.21 | 2022 | |
| Idorsia Pharmaceuticals US INC | $21.28 | 2022 | |
| Nevro Corp. | $16.57 | 2022 | |
| Pfizer INC. | $14.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maroun Dick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.